Evidence map›Paper›PMID 25181487›Full record

ArticlePloS one2014

Spared piriform cortical single-unit odor processing and odor discrimination in the Tg2576 mouse model of Alzheimer's disease.

Wenjin Xu, Mirielle Lopez-Guzman, Chelsea Schoen, Shane Fitzgerald, Stephanie L Lauer, Ralph A Nixon, Efrat Levy, Donald A Wilson

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2016
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenjin XuEmotional Brain Institute, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America; Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York, New York, United States of America.
Mirielle Lopez-GuzmanEmotional Brain Institute, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America.
Chelsea SchoenEmotional Brain Institute, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America.
Shane FitzgeraldEmotional Brain Institute, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America; Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America.
Stephanie L LauerEmotional Brain Institute, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America; Center for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America.
Ralph A NixonCenter for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America; Department of Psychiatry, New York University School of Medicine, New York, New York, United States of America; Department of Cell Biology, New York University School of Medicine, New York, New York, United States of America.
Efrat LevyCenter for Dementia Research, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America; Department of Psychiatry, New York University School of Medicine, New York, New York, United States of America; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, United States of America.
Donald A WilsonEmotional Brain Institute, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York, United States of America; Department of Child and Adolescent Psychiatry, New York University School of Medicine, New York, New York, United States of America; Department of Neuroscience and Physiology, New York University School of Medicine, New York, New York, United States of America.

Funding

Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal functionP01AG017617 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI NIXON, RALPH A. · 2000 to 2021
$40.0M
Modulation of Olfactory Sensory Function by Amyloid-betaR01AG037693 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI LEVY, EFRAT, NIXON, RALPH A. · 2011 to 2015
$1.6M
NIA NIH HHS P01 AG017617NIA NIH HHS R01 AG037693NIA NIH HHS R01-AG037693
6 · The paper itself

Abstract

Alzheimer's disease is a neurodegenerative disorder that is the most common cause of dementia in the elderly today. One of the earliest reported signs of Alzheimer's disease is olfactory dysfunction, which may manifest in a variety of ways. The present study sought to address this issue by investigating odor coding in the anterior piriform cortex, the primary cortical region involved in higher order olfactory function, and how it relates to performance on olfactory behavioral tasks. An olfactory habituation task was performed on cohorts of transgenic and age-matched wild-type mice at 3, 6 and 12 months of age. These animals were then anesthetized and acute, single-unit electrophysiology was performed in the anterior piriform cortex. In addition, in a separate group of animals, a longitudinal odor discrimination task was conducted from 3-12 months of age. Results showed that while odor habituation was impaired at all ages, Tg2576 performed comparably to age-matched wild-type mice on the olfactory discrimination task. The behavioral data mirrored intact anterior piriform cortex single-unit odor responses and receptive fields in Tg2576, which were comparable to wild-type at all age groups. The present results suggest that odor processing in the olfactory cortex and basic odor discrimination is especially robust in the face of amyloid β precursor protein (AβPP) over-expression and advancing amyloid β (Aβ) pathology. Odor identification deficits known to emerge early in Alzheimer's disease progression, therefore, may reflect impairments in linking the odor percept to associated labels in cortical regions upstream of the primary olfactory pathway, rather than in the basic odor processing itself.

Indexed as

OdorantsAlzheimer DiseaseAnimalsBehavior, AnimalBenzothiazolesDisease Models, AnimalEntorhinal CortexFemaleHabituation, PsychophysiologicHippocampusMaleMemoryMice, TransgenicOlfactory BulbOlfactory PathwaysPiriform CortexBenzothiazolesThiazolesthioflavin T

Identifiers

PMID25181487
PMCPMC4152226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.